Detalles de la búsqueda
1.
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials.
Haematologica
; 109(1): 245-255, 2024 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37439329
2.
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia.
Cancer
; 129(7): 992-1004, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36692409
3.
Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells.
Cell Biol Toxicol
; 39(3): 795-811, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34519926
4.
The power of telemedicine to improve CAR-T cell therapy programs: lessons learned from COVID-19 pandemic.
Support Care Cancer
; 31(6): 350, 2023 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37227523
5.
Network meta-analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant.
Hematol Oncol
; 40(5): 987-998, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35794705
6.
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials.
Hematol Oncol
; 40(4): 704-715, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35608183
7.
Patients with multiple myeloma referred for palliative care consultation: from retrospective analysis to future directions to improve clinical outcomes.
Support Care Cancer
; 30(3): 2293-2298, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34718886
8.
T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer.
Int J Mol Sci
; 23(15)2022 Aug 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35955721
9.
Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon.
Int J Mol Sci
; 23(21)2022 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36362130
10.
Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myeloma.
Support Care Cancer
; 29(11): 6973-6980, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33990881
11.
A Review of Clinical Outcomes of CAR T-Cell Therapies for B-Acute Lymphoblastic Leukemia.
Int J Mol Sci
; 22(4)2021 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-33670075
12.
An 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia.
Anticancer Drugs
; 31(1): 67-72, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31633499
13.
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study.
Am J Hematol
; 95(9): 1030-1037, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32419224
14.
Bendamustine plus Rituximab Versus R-CHOP as First-Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study.
Oncologist
; 23(4): 454-460, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29317554
15.
Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy.
Ann Hematol
; 97(6): 1009-1018, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29442162
16.
Lenalidomide at the dose of 25 mg every other day in patients affected by multiple myeloma and renal failure: a real-life experience.
Anticancer Drugs
; 29(4): 371-372, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29420336
17.
Safety and comfort of domestic bortezomib injection in real-life experience.
Support Care Cancer
; 26(9): 3111-3116, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29574618
18.
Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience.
Support Care Cancer
; 25(3): 839-845, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27812763
19.
Secondary syphilis mimicking malignancy: A case report and review of literature.
J Infect Chemother
; 23(8): 576-578, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28456488
20.
Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease.
J Med Virol
; 93(1): 124-126, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32579244